Search

Displaying results 781 - 790 of 10000 in total

Drug
Letermovir
go.drugbank.com/drugs/DB12070
ApprovedInvestigational
It is currently marketed under the brand name Prevymis.[L1021] … Letermovir recieved approval from the FDA on November 8th, 2017 for use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients.
Products: PREVYMIS 240mg/12mL (20mg/mL) concentrate for solution for infusion, PREVYMIS 240 MG SOLUCIÓN INYECTABLE
Drug
Butenafine
go.drugbank.com/drugs/DB01091
Approved
In particular, butenafine acts to inhibit the activity of the squalene epoxidase enzyme that is essential in the formation of sterols necessary for fungal cell membranes.
Synonyms: N-(p-tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine, (4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamineProducts: BUTAFLY %1 KREM,30G
Drug
Fluvoxamine
go.drugbank.com/drugs/DB00176
ApprovedInvestigational
Though it is in the same class as other SSRI drugs, it is most often used to treat obsessive-compulsive disorder. … It was launched in the US in December 1994 and in Japan in June 1999. As of the end of 1995, more than 10 million patients worldwide have been treated with fluvoxamine.
Products: FLUVOXAMINA EG, Gen-fluvoxamine 50mg
Drug
Methimazole
go.drugbank.com/drugs/DB00763
ApprovedInvestigational
[A184559,A184733,A184694] It was first introduced as an antithyroid agent in 1949[A184502] and is now commonly used in the management of hyperthyroidism, particularly in those for whom more aggressive … Despite documented teratogenic effects in its published labels,[L8336,L8339] the true teratogenicity of methimazole appears to be unclear[A184643,A184757,A184763] and its place in therapy may change in
Products: THIAMAZOL 10MG HEXAL, THIAMAZOL ARISTO 10MG
Drug
Gadoversetamide
go.drugbank.com/drugs/DB00538
Approved
Gadoversetamide, marketed under the trade name OptiMARK, is a gadolinium compound used as a contrast agent in magnetic resonance imaging (MRI), particularly imaging of the brain, spine and liver.
Categories: Compounds used in a research, industrial, or household settingProducts: CIPROFLOXACINA 100 MG / 10 ML, ENJ. ICIN COZ. ICEREN FLAKON, 10 ML
Drug
Coagulation factor VIIa Recombinant Human
go.drugbank.com/drugs/DB00036
ApprovedInvestigational
Cloned and expressed in hamster kidney cells, the protein is catalytically active in a two-chain form.
Products: powder and solvent for solution for injection 1mg, NOVOSEVEN 1MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Drug
Ranolazine
go.drugbank.com/drugs/DB00243
ApprovedInvestigational
It was originally approved by the FDA in 2006.[L5440]
Products: RANOLAZINA EG, Rande 375 mg Retardtabletten
Drug
Belimumab
go.drugbank.com/drugs/DB08879
ApprovedInvestigational
It is produced by recombinant DNA technology in a murine cell (NS0) expression system. … [L42630] Belimumab was first approved by the FDA on March 9, 2011,[A251495] making it the newest drug to be approved for the treatment of SLE in more than 50 years.
Products: Benlysta Powder for Solution for Infusion 120mg, BENLYSTA 200 MG / 1 ML
Target
Endothelin receptor type B
go.drugbank.com/bio_entities/BE0000043
TargetHumans
Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system
Synonyms: ET-B, ET-BR
Drug
Esomeprazole
go.drugbank.com/drugs/DB00736
ApprovedInvestigational
at the secretory surface of gastric parietal cells. … It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.
Mixtures: VONO 500 MG/20 MG DEĞİŞTİRİLMİŞ SALIMLI TABLET, 30 ADET, VONO 375 MG/20 MG DEĞİŞTİRİLMİŞ SALIMLI TABLET, 20 ADETInternational brands: ES-OD